N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients.
about
A Test in Context: Critical Evaluation of Natriuretic Peptide Testing in Heart FailureThe role of natriuretic peptides for the diagnosis of left ventricular dysfunctionNatriuretic peptide testing for predicting adverse events following heart failure hospitalizationNatriuretic peptides as biomarkers in heart failureChallenges in acute heart failure clinical management: optimizing care despite incomplete evidence and imperfect drugsHigh-sensitivity troponin T: a biomarker for diuretic response in decompensated heart failure patients.N-terminal pro-B-type natriuretic peptide as a diagnostic test for ventricular dysfunction in patients with coronary disease: data from the heart and soul studyNatriuretic Peptide testing in primary carePrognostic implication of physical signs of congestion in acute heart failure patients and its association with steady-state biomarker levelsPlasma NT pro-BNP, hs-CRP and big-ET levels at admission as prognostic markers of survival in hospitalized patients with dilated cardiomyopathy: a single-center cohort studyNatriuretic peptides (BNP and NT-proBNP): measurement and relevance in heart failureAdmission, discharge, or change in B-type natriuretic peptide and long-term outcomes: data from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF) linked to Medicare claims.Combination of uric acid and NT-ProBNP: a more useful prognostic marker for short-term clinical outcomes in patients with acute heart failureB-type natriuretic peptide-guided therapy for perioperative medicine?Association of cardiac and renal function with extreme N-terminal fragment pro-B-type natriuretic peptide levels in elderly patients.Rationale and design of MinerAlocorticoid Receptor antagonist Tolerability Study-Heart Failure (ARTS-HF): a randomized study of finerenone vs. eplerenone in patients who have worsening chronic heart failure with diabetes and/or chronic kidney diseasThe role of plasma biomarkers in acute heart failure. Serial changes and independent prognostic value of NT-proBNP and cardiac troponin-T.Early diagnosis of rats with acute myocardial infarction by measurement of brain natriuretic peptide.B-type natriuretic peptide predicts 30-day readmission for heart failure but not readmission for other causes.Dynamics of the liver stiffness value using transient elastography during the perioperative period in patients with valvular heart disease.Influence of spironolactone on matrix metalloproteinase-2 in acute decompensated heart failure.Direct comparison of serial B-type natriuretic peptide and NT-proBNP levels for prediction of short- and long-term outcome in acute decompensated heart failure.In-hospital brain natriuretic peptide and N-terminal prohormone brain natriuretic peptide variations are predictors of short-term and long-term outcome in acute decompensated heart failure.Correlation between B-Type Natriuretic Peptide and Functional/Cognitive Parameters in Discharged Congestive Heart Failure Patients.Serial measurements of midregion proANP and copeptin in ambulatory patients with heart failure: incremental prognostic value of novel biomarkers in heart failure.Plasma N-terminal pro-B-type natriuretic peptide as long-term prognostic marker after major vascular surgery.Serum procalcitonin is a marker for prediction of readmission from an intermediate care to an acute care hospital in neurosurgical patients.N-terminal proBNP: a novel biomarker for the diagnosis, risk stratification and management of congestive heart failure.Prognostic utility of novel biomarkers of cardiovascular stress in patients with aortic stenosis undergoing valve replacement.Postoperative B-type natriuretic Peptide levels associated with prolonged hospitalization in hypertensive patients after non-cardiac surgery.Multidisciplinary Assessment to Personalize Length of Stay in Acute Decompensated Heart Failure (OPTIMA II ADHF)Clinical relevance of biological variation: the lesson of brain natriuretic peptide (BNP) and NT-proBNP assay.N-Terminal Pro-Brain Natriuretic Peptide and Heart Failure Risk Among Individuals With and Without Obesity: The Atherosclerosis Risk in Communities (ARIC) Study.Biomarkers for heart failure.The association between disease activity and NT-proBNP in 238 patients with rheumatoid arthritis: a 10-year longitudinal study.Early pharmacological treatment of acute heart failure syndromes: a systematic review of clinical trials.Parallel evolution of circulating FABP4 and NT-proBNP in heart failure patients.Physiology and clinical significance of natriuretic hormonesAtrial natriuretic peptide and related peptides.Revised prognostic staging system for light chain amyloidosis incorporating cardiac biomarkers and serum free light chain measurements.
P2860
Q26770151-4C8DD0A3-C90C-414E-880A-B72570EDF1C8Q26825665-B2B6AB82-1226-4D8A-B467-A0593EE34CD9Q27008553-8D923242-EE65-484D-9A6C-459557F5AA6EQ27012872-615AB6CF-0B03-467E-B842-56977351E95BQ28085736-4A019613-3507-4A7D-B8D8-9D176DF9075DQ30854596-FEC342F1-B02D-4181-B309-4EC25ED776E8Q31105305-DC6BE5A8-DCA9-4B76-99B4-9B7BE102568DQ33572286-B4599CD5-2E9B-4D85-B832-0CA3C7B48EF6Q33572791-77BB9E2D-7177-4C16-BCEB-EADC6AD9F746Q33699467-FBE2CCFA-F1AF-4BC9-9248-3352CB87F2FEQ33902623-F3A5A0CC-A35F-4DD8-9D34-EC543F83E56FQ33956698-FB86C201-28DC-4DC0-BD8D-1452C4ADC57DQ34102097-D8DF3B7A-4E3D-407D-AACE-E1D156123E86Q34304406-EDCC2007-1043-4737-92B3-652F0E5320EAQ34352658-D51BB83F-6B00-437B-B506-9FDBCE9F4FCEQ34462504-A75A1D78-1E04-455D-8CF3-A34C0D53D2BDQ34580385-91387226-81FB-4383-A0F2-E129F59E9696Q34676067-84C9B801-1F0F-46B1-911D-E8CCA14F96C4Q35021886-EA8C1525-60CC-47B2-8A3D-2C945F125F4FQ35132121-68F9C873-1473-4B01-BF40-CA25A9E69859Q35557972-F4DCF2D0-A4BF-496E-B051-323A09068A95Q35567128-FD77C6F6-D81F-4E0E-B825-A95D2C12762BQ35567228-9D323E53-C4C6-4F31-9BFB-EDDFB541D345Q35573378-5303E591-29B7-4B0B-B1FF-05BF7E552B60Q35748736-A78004EA-7166-49F2-940F-46A4727F8640Q35773192-0E9985D5-0D70-4538-98B1-F0312A8D5F40Q36032212-22D3A4A4-6EAE-4C51-93C1-764569B8D3BCQ36124913-0C5716DB-C133-4D87-AA16-C0D62A731144Q36136687-42AD3696-A346-46C1-A10E-E0846054539CQ36223062-8ABA0206-BB47-4AE2-8B3F-02EF6A42B513Q36442087-11A8BCB0-884C-4F1A-BEF1-0AA8F2699F9EQ36442407-58C8089E-B172-48CA-9478-8AC61A0436A4Q36593924-A091D89C-8492-48BA-B98A-7E52037AEB76Q36684774-EFD4D448-D624-453C-BB6F-FD3CD10BB78DQ36790405-2B18E776-0971-4B95-9720-EBEE9F6CE7FFQ36799331-BE6DEAA6-4672-4B63-B929-3ADA311F6685Q36843359-F216E817-A1D2-4F38-A935-171D0263C8B0Q36862282-F0A3DCF2-40F1-40B4-902F-2F828EDDC712Q36896608-696DB411-C57E-4B31-9EA1-801C59E6CA7BQ36910372-8DD28DCD-7619-4FDA-B90D-C200EC14C030
P2860
N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
N-terminal-pro-brain natriuret ...... rge in heart failure patients.
@en
type
label
N-terminal-pro-brain natriuret ...... rge in heart failure patients.
@en
prefLabel
N-terminal-pro-brain natriuret ...... rge in heart failure patients.
@en
P50
P1433
P1476
N-terminal-pro-brain natriuret ...... rge in heart failure patients.
@en
P2093
Susana Ferreira
P304
P356
10.1161/01.CIR.0000144310.04433.BE
P407
P577
2004-09-27T00:00:00Z